Patent · US Active

Method and filamentous phage for treating inflammation associated with amyloid deposits and brain inflammation involving activated microglia

US8361458B2 · kind B2 · utility

0Cited by

0References

16Claims

0Family size

Assignee

Ramot at Tel-Aviv University Ltd. · IL

Inventors

Beka Solomon · Herzliya, IL
Orna Goren · Shoham, IL

Key dates

Filing date	Dec 13, 2010
Grant date	Jan 29, 2013
Priority date	—
Expiry date	Dec 13, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2795/14171
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Filamentous bacteriophage which does not display an antibody or a non-filamentous bacteriophage antigen on its surface is used to inhibit or treat brain inflammation associated with amyloid deposits and/or involving activated microglia, to inhibit the formation of amyloid deposits, and to disaggregate pre-formed amyloid deposits.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.